Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene–gene interaction
- 31 October 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 99 (1) , 113-118
- https://doi.org/10.1016/j.ygyno.2005.05.010
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Genetic polymorphism of the interferon‐γ gene in cervical carcinogenesisInternational Journal of Cancer, 2004
- No evidence of the involvement of the Fas −670 promoter polymorphism in cervical cancer in situInternational Journal of Cancer, 2004
- Inflammation and cancerNature, 2002
- Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesisInternational Journal of Cancer, 2002
- CYP1A1, GSTM1, and GSTT1 Polymorphisms and the Risk of Cervical Squamous Intraepithelial Lesions in a Multiethnic PopulationGynecologic Oncology, 2001
- Up-regulation of Fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillanceHepatology, 2000
- The Hallmarks of CancerCell, 2000
- Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical CancerNew England Journal of Medicine, 1999
- Effects of Cigarette Smoking on Fas/Fas Ligand Expression of Human LymphocytesCellular Immunology, 1999
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995